Surakit Nathisuwan, Robert L Talbert. Pharmacotherapy 2002
Times Cited: 35
Times Cited: 35
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng, Tsu-Han Lin, Weiyi Zheng, William P Dole. J Clin Pharmacol 2010
Times Cited: 355
Times Cited: 355
List of shared articles
Times cited
Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?
Vasiliki Katsi, Georgios Skalis, Antonis N Pavlidis, Thomas Makris, Petros Nihoyannopoulos, Dimitris Tousoulis, Ioannis Kallikazaros. Eur Heart J Cardiovasc Pharmacother 2015
Vasiliki Katsi, Georgios Skalis, Antonis N Pavlidis, Thomas Makris, Petros Nihoyannopoulos, Dimitris Tousoulis, Ioannis Kallikazaros. Eur Heart J Cardiovasc Pharmacother 2015
Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice.
Ya Suo, Meng Yuan, Hongmin Li, Yue Zhang, Ying Li, Huaying Fu, Fei Han, Changhui Ma, Yuanyuan Wang, Qiankun Bao,[...]. Front Pharmacol 2019
Ya Suo, Meng Yuan, Hongmin Li, Yue Zhang, Ying Li, Huaying Fu, Fei Han, Changhui Ma, Yuanyuan Wang, Qiankun Bao,[...]. Front Pharmacol 2019
Angiotensin receptor-neprilysin inhibitor attenuates cardiac hypertrophy and improves diastolic dysfunction in a mouse model of heart failure with preserved ejection fraction.
Yue Zhang, Meng Yuan, Ya Suo, Qian Yang, Shuai Shao, Ying Li, Yuanyuan Wang, Qiankun Bao, Tong Liu, Guangping Li. Clin Exp Pharmacol Physiol 2022
Yue Zhang, Meng Yuan, Ya Suo, Qian Yang, Shuai Shao, Ying Li, Yuanyuan Wang, Qiankun Bao, Tong Liu, Guangping Li. Clin Exp Pharmacol Physiol 2022
In silico study of inhibitory capacity of sacubitril/valsartan toward neprilysin and angiotensin receptor.
Jelena Đorović Jovanović, Marko Antonijević, Radiša Vojinović, Nenad D Filipović, Zoran Marković. RSC Adv 2022
Jelena Đorović Jovanović, Marko Antonijević, Radiša Vojinović, Nenad D Filipović, Zoran Marković. RSC Adv 2022
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond.
Jagdeep S S Singh, Chim C Lang. Vasc Health Risk Manag 2015
Jagdeep S S Singh, Chim C Lang. Vasc Health Risk Manag 2015